Practical, stereoselective synthesis of palinavir, a potent HIV protease inhibitor

被引:72
作者
Beaulieu, PL
Lavallee, P
Abraham, A
Anderson, PC
Boucher, C
Bousquet, Y
Duceppe, JS
Gillard, J
Gorys, V
GrandMaitre, C
Grenier, L
Guindon, Y
Guse, I
Plamondon, L
Soucy, F
Valois, S
Wernic, D
Yoakim, C
机构
[1] Bio-Méga Research Division, Boehringer Ingelheim (Canada) Ltd., Laval, Que. H7S 2G5
[2] ProScript, Inc., Cambridge, MA 02139
关键词
D O I
10.1021/jo9702655
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Palinavir is a potent peptidomimetic-based HIV protease inhibitor. We have developed a highly convergent and stereoselective synthesis which is amenable to the preparation of multikilogram quantities of this compound. The synthetic sequence proceeds in 24 distinct chemical steps (with several integrated, multistep operations) from commercially available starting materials. No chromatographies are required throughout the process, and the final product is purified by crystallization of its dihydrochloride salt to >99% homogeneity.
引用
收藏
页码:3440 / 3448
页数:9
相关论文
共 54 条
[1]   STEREOCONTROLLED SYNTHESIS OF ERYTHRO N-PROTECTED ALPHA-AMINO EPOXIDES AND PEPTIDYL EPOXIDES [J].
ALBECK, A ;
PERSKY, R .
TETRAHEDRON, 1994, 50 (21) :6333-6346
[2]  
Anderson P.C., 1996, US Patent, Patent No. [5.545.640, 5545640]
[3]   THE FIRST DIRECT PREPARATION OF CHIRAL FUNCTIONALIZED KETONES AND THEIR SYNTHETIC USES [J].
BARLUENGA, J ;
BARAGANA, B ;
ALONSO, A ;
CONCELLON, JM .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1994, (08) :969-970
[4]   HIGHLY DIASTEREOSELECTIVE SYNTHESIS OF THREO OR ERYTHRO AMINOALKYL EPOXIDES FROM ALPHA-AMINO-ACIDS [J].
BARLUENGA, J ;
BARAGANA, B ;
CONCELLON, JM .
JOURNAL OF ORGANIC CHEMISTRY, 1995, 60 (21) :6696-6699
[5]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[6]   AMINODIOL HIV PROTEASE INHIBITORS .1. DESIGN, SYNTHESIS, AND PRELIMINARY SAR [J].
BARRISH, JC ;
GORDON, E ;
ALAM, M ;
LIN, PF ;
BISACCHI, GS ;
CHEN, P ;
CHENG, PTW ;
FRITZ, AW ;
GREYTOK, JA ;
HERMSMEIER, MA ;
HUMPHREYS, WG ;
LIS, KA ;
MARELLA, MA ;
MERCHANT, Z ;
MITT, T ;
MORRISON, RA ;
OBERMEIER, MT ;
PLUSCEC, J ;
SKOOG, M ;
SLUSARCHYK, WA ;
SPERGEL, SH ;
STEVENSON, JM ;
SUN, CQ ;
SUNDEEN, JE ;
TAUNK, P ;
TINO, JA ;
WARRACK, BM ;
COLONNO, RJ ;
ZAHLER, R .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (12) :1758-1768
[7]   THE BODROUX REACTION [J].
BASSETT, HL ;
THOMAS, CR .
JOURNAL OF THE CHEMICAL SOCIETY, 1954, (APR) :1188-1190
[8]   Preparation of aminoalkyl chlorohydrin hydrochlorides: Key building blocks for hydroxyethylamine-based HIV protease inhibitors [J].
Beaulieu, PL ;
Wernic, D .
JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (11) :3635-3645
[9]   LARGE-SCALE PREPARATION OF (2S,3S)-N-BOC-3-AMINO-1,2-EPOXY-4-PHENYLBUTANE - A KEY BUILDING-BLOCK FOR HIV-PROTEASE INHIBITORS [J].
BEAULIEU, PL ;
WERNIC, D ;
DUCEPPE, JS ;
GUINDON, Y .
TETRAHEDRON LETTERS, 1995, 36 (19) :3317-3320
[10]  
BEAULIEU PL, 1997, IN PRESS J MED CHEM